News
Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ETCompany ParticipantsSiting Li - IR DirectorStanley Peng - ...
Patient dosing underway in CALiPSO-1 trial in the U.S.: In March 2025, the first patient was dosed in the Phase 1 CALiPSO-1 trial which is currently evaluating CNTY-101 as a potential treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback